PAQ Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $77M

  • Investors
  • 12

PAQ Therapeutics General Information

Description

Operator of a biotechnology company intended to restore health and cure disease through autophagy. The company develops a novel class of small-molecule degraders through autophagosome-tethering compound technology capable of binding a diverse array of substrates to the autophagy pathway, enabling physicians to create cures and overcome serious diseases where therapeutic options are limited for patients.

Contact Information

Website
www.paqtx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 625 Mass Avenue
  • Office 02-146
  • Cambridge, MA 02139
  • United States
+1 (916)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 625 Mass Avenue
  • Office 02-146
  • Cambridge, MA 02139
  • United States
+1 (916)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PAQ Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series B) 22-Jan-2026 $77M Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC (Series A) 15-Jul-2021 $30M $34M Completed Generating Revenue
1. Seed Round 08-Nov-2020 $4M $4M Completed Generating Revenue
To view PAQ Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

PAQ Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to restore health and cure disease through autophagy. The company develops
Drug Discovery
Cambridge, MA
10 As of 2025

New York, NY
 

Broomfield, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

PAQ Therapeutics Competitors (73)

One of PAQ Therapeutics’s 73 competitors is Neurogene, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurogene Formerly VC-backed New York, NY
Cerecin Venture Capital-Backed Broomfield, CO
Kymera Therapeutics Formerly VC-backed Watertown, MA
Asceneuron Venture Capital-Backed Eysins, Switzerland
TauRx Pharmaceuticals Private Equity-Backed Aberdeen, United Kingdom
You’re viewing 5 of 73 competitors. Get the full list »

PAQ Therapeutics Patents

PAQ Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024355429-A1 Kras proteolysis targeting chimeras Pending 03-Oct-2023
EP-4788683-A1 Kras proteolysis targeting chimeras Pending 03-Oct-2023
US-12599672-B2 Kras proteolysis targeting chimeras Active 03-Oct-2023
US-20250144225-A1 Kras proteolysis targeting chimeras Active 03-Oct-2023
WO-2025076044-A1 Kras proteolysis targeting chimeras Inactive 03-Oct-2023 A61K47/55
To view PAQ Therapeutics’s complete patent history, request access »

PAQ Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PAQ Therapeutics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bayland Capital Corporate Venture Capital Minority
BioTrack Capital Venture Capital Minority
Johnson & Johnson Innovation - JLABS Accelerator/Incubator Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
LAV Fund Corporation Minority
You’re viewing 5 of 12 investors. Get the full list »

PAQ Therapeutics FAQs

  • When was PAQ Therapeutics founded?

    PAQ Therapeutics was founded in 2020.

  • Where is PAQ Therapeutics headquartered?

    PAQ Therapeutics is headquartered in Cambridge, MA.

  • What is the size of PAQ Therapeutics?

    PAQ Therapeutics has 10 total employees.

  • What industry is PAQ Therapeutics in?

    PAQ Therapeutics’s primary industry is Drug Discovery.

  • Is PAQ Therapeutics a private or public company?

    PAQ Therapeutics is a Private company.

  • What is PAQ Therapeutics’s current revenue?

    The current revenue for PAQ Therapeutics is .

  • How much funding has PAQ Therapeutics raised over time?

    PAQ Therapeutics has raised $111M.

  • Who are PAQ Therapeutics’s investors?

    Bayland Capital, BioTrack Capital, Johnson & Johnson Innovation - JLABS, Johnson & Johnson JJDC, and LAV Fund are 5 of 12 investors who have invested in PAQ Therapeutics.

  • Who are PAQ Therapeutics’s competitors?

    Neurogene, Cerecin, Kymera Therapeutics, Asceneuron, and TauRx Pharmaceuticals are some of the 73 competitors of PAQ Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process